9
Views
0
CrossRef citations to date
0
Altmetric
Articles

Lectin-Gold Staining of Sialic Acid in Mesotheliomas and Pulmonary Adenocarcinomas

Pages 31-34 | Published online: 18 Jul 2013
 

Abstract

Lectin-gold staining and electron microscopy techniques were used to determine the sialic acid patterns of epithelial mesotheliomas and pulmonary adenocarcinomas. Pulmonary adenocarcinomas and 4 malignant epithelial mesotheliomas from human tissue banks were used. Tissues were fixed in a mixture of 3% parafomaldehyde and 0.1% glutaraldehyde for 2 hr, dehydrated in increasing concentrations of ethanol, and embedded in Lowicryl K4M. Ultrathin sections on 150-mesh nickel grids were incubated with LimaxJavus lectin-gold (LFL-gl0), Sambucus nigrans lectin-gold (SNL-gl4), and Maackia amurensis lectin-gold (MAL-gl4). Both mesotheliomas and adenocarcinomas stained positively with (LFL-gl0) and (MAL-g14) and negatively with (SNL-gl4). Positive staining with MAL-g14 and an absence of staining with SNL-g14 show the terminal sialic acid linkage to D-galactose to be α2,3, rather than α2,6. Although, mesotheliomas stained with MAL-g14 had significantly more gold particles than did adenocarcinomas, the gold particle to cell membrane ratio was not different between the two. Therefore these lectins were not helpful in differentiating mesotheliomas and adenocarcinomas. (The J Histotechnol 20:31, 1997)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.